NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea · Delayed Price · Currency is KRW 764.00
-77.00 (-9.16%)
At close: Oct 2, 2026
NGeneBio Market Cap
NGeneBio has a market cap or net worth of 12.29 billion as of October 2, 2026. Its market cap has decreased by -71.38% in one year.
Market Cap
12.29B
Enterprise Value
41.67B
Revenue
41.80B
Ranking
n/a
PE Ratio
n/a
Stock Price
764.00
ChartMarket Cap Chart
Since December 10, 2020, NGeneBio's market cap has decreased from 313.33B to 12.29B, a decrease of -96.08%. That is a compound annual growth rate of -42.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 12.29B | -66.38% |
| Dec 30, 2025 | 36.56B | 12.79% |
| Dec 30, 2024 | 32.41B | -54.77% |
| Dec 28, 2023 | 71.66B | -38.24% |
| Dec 29, 2022 | 116.03B | -42.38% |
| Dec 30, 2021 | 201.38B | -46.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| Epibiotech | 33.59B |
| Shaperon | 24.37B |
| Poongjeon Pharmacy CO.,LTD. | 20.60B |
| Moogene Medi | 19.09B |
| Plumbline Life Sciences | 18.69B |
| MOA Life Plus | 10.10B |